Proposed model of the proleukemogenic cooperation of TCL1A with TCR signaling. TCL1A confers a survival benefit, supported by the effect of additional genomic alterations (eg, ATM) and contributes to resistance to programmed cell death (AICD). The figure has been adapted from Figure 7E in the article by Oberbeck et al that begins on page 2786.